Dr. Bradley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Bradley is a board-certified ophthalmologist specializing in oculofacial plastic surgery. Her special interest is caring for patients with complex eyelid, orbit, and nasolacrimal problems through multi-specialty care teams. She is a member of Mayo Clinic's face transplant team, and is a co-founder of Mayo's multi-disciplinary Facial Reanimation Clinic and Thyroid Eye Disease Clinic. Her areas of surgical expertise include orbital decompression surgery, orbital biopsy, eyelid reconstruction, facial nerve rehabilitation, and tear drainage surgery.
Education & Training
- Mayo ClinicFellowship, Oculofacial Plastic Surgery, 1997 - 1998
- Johns Hopkins UniversityFellowship, Neuro-Ophthalmology, 1996 - 1997
- Wills Eye HospitalResidency, 1993 - 1996
- University of Michigan Medical SchoolClass of 1992
Certifications & Licensure
- MN State Medical License 1997 - 2025
- WI State Medical License 2011 - 2019
- IA State Medical License 1998 - 2005
- MD State Medical License 1996 - 2000
- PA State Medical License 1994 - 2000
- American Board of Ophthalmology Ophthalmology
- American Society of Ophthalmic Plastic and Reconstructive SurgeonsMember
Clinical Trials
- Exparel Injection for Postoperative Orbital Pain Start of enrollment: 2015 Feb 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 221 citationsRandomized Controlled Trial of Rituximab in Patients With Graves' OrbitopathyMarius N. Stan, James A. Garrity, Barbara G. Carranza Leon, Thapa Prabin, Elizabeth A. Bradley
The Journal of Clinical Endocrinology and Metabolism. 2015-02-01 - 500 citationsCardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials.David J. Bradley, Elizabeth A. Bradley, Kenneth L. Baughman, Ronald D. Berger, Hugh Calkins
JAMA. 2003-02-12 - 10 citationsProof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease.George J Kahaly, Peter J Dolman, Jan Wolf, Bert C Giers, Heike M Elflein
The Journal of Clinical Endocrinology and Metabolism. 2023-11-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: